• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

艰难梭菌:其所致疾病与毒素

Clostridium difficile: its disease and toxins.

作者信息

Lyerly D M, Krivan H C, Wilkins T D

机构信息

Department of Anaerobic Microbiology, Virginia Polytechnic Institute and State University, Blacksburg 24061.

出版信息

Clin Microbiol Rev. 1988 Jan;1(1):1-18. doi: 10.1128/CMR.1.1.1.

DOI:10.1128/CMR.1.1.1
PMID:3144429
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC358025/
Abstract

Clostridium difficile is the etiologic agent of pseudomembranous colitis, a severe, sometimes fatal disease that occurs in adults undergoing antimicrobial therapy. The disease, ironically, has been most effectively treated with antibiotics, although some of the newer methods of treatment such as the replacement of the bowel flora may prove more beneficial for patients who continue to relapse with pseudomembranous colitis. The organism produces two potent exotoxins designated toxin A and toxin B. Toxin A is an enterotoxin believed to be responsible for the diarrhea and mucosal tissue damage which occur during the disease. Toxin B is an extremely potent cytotoxin, but its role in the disease has not been as well studied. There appears to be a cascade of events which result in the expression of the activity of these toxins, and these events, ranging from the recognition of a trisaccharide receptor by toxin A to the synergistic action of the toxins and their possible dissemination in the body, are discussed in this review. The advantages and disadvantages of the various assays, including tissue culture assay, enzyme immunoassay, and latex agglutination, currently used in the clinical diagnosis of the disease also are discussed.

摘要

艰难梭菌是伪膜性结肠炎的病原体,伪膜性结肠炎是一种严重的、有时甚至致命的疾病,发生于接受抗菌治疗的成年人中。具有讽刺意味的是,尽管一些新的治疗方法,如肠道菌群置换,可能对伪膜性结肠炎持续复发的患者更有益,但该疾病最有效的治疗方法仍是使用抗生素。该微生物产生两种强效外毒素,分别称为毒素A和毒素B。毒素A是一种肠毒素,被认为是导致疾病期间腹泻和粘膜组织损伤的原因。毒素B是一种极其强效的细胞毒素,但其在疾病中的作用尚未得到充分研究。似乎存在一系列导致这些毒素活性表达的事件,本文将讨论这些事件,从毒素A对三糖受体的识别到毒素的协同作用及其在体内可能的传播。本文还讨论了目前用于该疾病临床诊断的各种检测方法的优缺点,包括组织培养检测、酶免疫检测和乳胶凝集检测。

相似文献

1
Clostridium difficile: its disease and toxins.艰难梭菌:其所致疾病与毒素
Clin Microbiol Rev. 1988 Jan;1(1):1-18. doi: 10.1128/CMR.1.1.1.
2
[Clostridium difficile-induced enterocolitis: pathogenesis, clinical course, epidemiology and laboratory diagnosis].艰难梭菌所致小肠结肠炎:发病机制、临床病程、流行病学及实验室诊断
Immun Infekt. 1986 Apr;14(2):63-7.
3
Diagnosis of Clostridium difficile-associated intestinal disease.艰难梭菌相关性肠道疾病的诊断
Crit Rev Clin Lab Sci. 1986;24(3):235-61. doi: 10.3109/10408368609110275.
4
Optimal methods for identifying Clostridium difficile infections.鉴定艰难梭菌感染的最佳方法。
Clin Infect Dis. 1993 Jun;16 Suppl 4:S439-42. doi: 10.1093/clinids/16.supplement_4.s439.
5
Theodore E. Woodward Award. How bacterial enterotoxins work: insights from in vivo studies.西奥多·E·伍德沃德奖。细菌肠毒素的作用机制:来自体内研究的见解。
Trans Am Clin Climatol Assoc. 2002;113:167-80; discussion 180-1.
6
Cytotoxin and enterotoxin production by Clostridium difficile.艰难梭菌产生的细胞毒素和肠毒素
Microbiologica. 1984 Oct;7(4):375-9.
7
Colitis caused by Clostridium difficile: a review.艰难梭菌引起的结肠炎:综述
Am J Med Technol. 1982 Nov;48(11):927-34.
8
Comparison of culture, cytotoxicity assays, and enzyme-linked immunosorbent assay for toxin A and toxin B in the diagnosis of Clostridium difficile-related enteric disease.用于艰难梭菌相关性肠道疾病诊断的培养法、细胞毒性测定法以及毒素A和毒素B的酶联免疫吸附测定法的比较
Diagn Microbiol Infect Dis. 1986 May;5(1):61-9. doi: 10.1016/0732-8893(86)90092-1.
9
Clostridium difficile and antibiotic associated diarrhoea in Sweden.瑞典的艰难梭菌与抗生素相关性腹泻
Scand J Infect Dis Suppl. 1982;35:53-8.
10
Lack of value of repeat stool testing for Clostridium difficile toxin.艰难梭菌毒素重复粪便检测的价值缺失
Am J Med. 2006 Apr;119(4):356.e7-8. doi: 10.1016/j.amjmed.2005.08.026.

引用本文的文献

1
Flagellar switch inverted repeats impact heterogeneity in flagellar gene expression and thus C. difficile RT027/MLST1 virulence.鞭毛开关反向重复序列影响鞭毛基因表达的异质性,进而影响艰难梭菌RT027/MLST1的毒力。
Cell Rep. 2025 Jun 24;44(6):115830. doi: 10.1016/j.celrep.2025.115830. Epub 2025 Jun 11.
2
Diagnosis of infection and impact of testing.感染的诊断与检测的影响
J Med Microbiol. 2024 Dec;73(12). doi: 10.1099/jmm.0.001939.
3
Flagellar switch inverted repeat impacts flagellar invertibility and varies RT027/MLST1 virulence.鞭毛开关反向重复序列影响鞭毛的可逆性并改变RT027/MLST1毒力。
bioRxiv. 2024 Sep 24:2023.06.22.546185. doi: 10.1101/2023.06.22.546185.
4
Insights into Gut Dysbiosis: Inflammatory Diseases, Obesity, and Restoration Approaches.肠道微生态失调的研究进展:炎症性疾病、肥胖症及相关修复策略
Int J Mol Sci. 2024 Sep 8;25(17):9715. doi: 10.3390/ijms25179715.
5
An Updated View on the Cellular Uptake and Mode-of-Action of Clostridioides difficile Toxins.艰难梭菌毒素的细胞摄取和作用模式的最新研究进展
Adv Exp Med Biol. 2024;1435:219-247. doi: 10.1007/978-3-031-42108-2_11.
6
Exploring the inhibitory potential of the antiarrhythmic drug amiodarone against toxins TcdA and TcdB.探讨抗心律失常药物胺碘酮对 TcdA 和 TcdB 毒素的抑制潜力。
Gut Microbes. 2023 Dec;15(2):2256695. doi: 10.1080/19490976.2023.2256695. Epub 2023 Sep 25.
7
Co-administration of an effector antibody enhances the half-life and therapeutic potential of RNA-encoded nanobodies.效应抗体的联合给药增强了 RNA 编码纳米抗体的半衰期和治疗潜力。
Sci Rep. 2023 Sep 5;13(1):14632. doi: 10.1038/s41598-023-41092-7.
8
Host Immunity and Immunization Strategies for Clostridioides difficile Infection.艰难梭菌感染的宿主免疫与免疫策略。
Clin Microbiol Rev. 2023 Jun 21;36(2):e0015722. doi: 10.1128/cmr.00157-22. Epub 2023 May 10.
9
Diversity, Dynamics and Therapeutic Application of Bacteriophages.噬菌体的多样性、动态性及其治疗应用。
Viruses. 2022 Dec 12;14(12):2772. doi: 10.3390/v14122772.
10
Potential Probiotic Properties of Exopolysaccharide-Producing EPS DA-BACS and Prebiotic Activity of Its Exopolysaccharide.产胞外多糖的EPS DA - BACS的潜在益生菌特性及其胞外多糖的益生元活性
Microorganisms. 2022 Dec 8;10(12):2431. doi: 10.3390/microorganisms10122431.

本文引用的文献

1
Pseudo-membranous colitis.伪膜性结肠炎
Gut. 1965 Jun;6(3):207-12. doi: 10.1136/gut.6.3.207.
2
A new method for the large-scale production of high-titre botulinum formol-toxoid types C and D.一种大规模生产高滴度C型和D型肉毒杆菌甲醛类毒素的新方法。
J Immunol. 1950 Aug;65(2):175-83.
3
Clostridia colonization and clostridial toxin in neonatal necrotizing enterocolitis.新生儿坏死性小肠结肠炎中的梭菌定植与梭菌毒素
J Pediatr. 1981 Feb;98(2):308-11. doi: 10.1016/s0022-3476(81)80667-1.
4
Clinical and laboratory observations in Clostridium difficile colitis.艰难梭菌结肠炎的临床及实验室观察
Am J Clin Nutr. 1980 Nov;33(11 Suppl):2521-6. doi: 10.1093/ajcn/33.11.2521.
5
Role of Clostridium difficile in a case of nonantibiotic-associated pseudomembranous colitis.艰难梭菌在一例非抗生素相关性假膜性结肠炎病例中的作用。
Gastroenterology. 1980 Nov;79(5 Pt 1):948-51.
6
Production of Clostridium difficile antitoxin.艰难梭菌抗毒素的生产
Infect Immun. 1980 Jun;28(3):1041-3. doi: 10.1128/iai.28.3.1041-1043.1980.
7
In vitro susceptibility of Clostridium difficile isolates from patients with antibiotic-associated diarrhea or colitis.来自抗生素相关性腹泻或结肠炎患者的艰难梭菌分离株的体外药敏性。
Antimicrob Agents Chemother. 1980 Apr;17(4):695-8. doi: 10.1128/AAC.17.4.695.
8
Non-antibiotic-associated pseudomembranous colitis due to toxin-producing Clostridia.由产毒素梭状芽孢杆菌引起的非抗生素相关性假膜性结肠炎。
Ann Intern Med. 1980 Jun;92(6):798-9. doi: 10.7326/0003-4819-92-6-798.
9
Clostridium difficile in gnotobiotic mice.悉生小鼠中的艰难梭菌。
Infect Immun. 1980 Apr;28(1):277-82. doi: 10.1128/iai.28.1.277-282.1980.
10
Cecal toxin(s) from guinea pigs with clindamycin-associated colitis, neutralized by Clostridium sordellii antitoxin.来自患有克林霉素相关性结肠炎的豚鼠的盲肠毒素,被索氏梭菌抗毒素中和。
Infect Immun. 1980 Feb;27(2):387-90. doi: 10.1128/iai.27.2.387-390.1980.